Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 70 years old
- People who have signed a written agreement to take part in the study
- People whose heart, liver, kidneys, and other major organs are working well enough, and who are generally well enough to carry out light activity or normal daily tasks (ECOG score of 0 or 1)
- People who have not received any systemic treatment for their condition at the time of joining the study
- People whose cervical cancer has been classified as stage IB3, IIA2, or IIIC1r using the FIGO 2018 staging system (confirm with trial site)
- People whose cancer has been confirmed by a tissue sample (biopsy) to be squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the cervix
- People whose cancer has at least one area that can be measured using standard imaging guidelines (RECIST v1.1)
- People who are willing to have blood and tumour tissue samples collected and tested
- People whose blood test results meet specific levels, including haemoglobin, white blood cells, and platelets, without having had a blood transfusion in the 14 days before testing (confirm with trial site for exact values)
- People whose liver function blood test results fall within acceptable ranges for certain markers (confirm with trial site for exact values)
- People who are able and willing to attend all scheduled visits, follow the study plan, and complete all required tests and procedures
Who may not be able to join:
- People who have had another cancer diagnosis within the past 3 years
- People who are currently taking part in another clinical trial
- People who have an autoimmune disease that currently requires ongoing systemic (whole-body) treatment
- People who have an active infection that currently requires ongoing systemic treatment
- People who have previously had a transplant of tissue or a solid organ from another person
- People with serious health conditions, such as severe mental health disorders, heart disease, blood clotting problems, or serious digestive system conditions
- People with an active hepatitis B, hepatitis C, or HIV infection
- People who are pregnant or currently breastfeeding
- People with a current problem with drug or alcohol misuse
- People who are unable or unwilling to sign the informed consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-15959028989
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological complete response (pCR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.